Yulan Sun

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

Xiao Han, Xiaoyong Tang, Hui Zhu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 20 citations · Full text

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Chunyue Wang, Zhenlong Zhang, Yulan Sun et al. · Journal of Translational Medicine · 2022 · 18 citations · Full text

Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center

Yuying Li, Jing Wang, Xuquan Jing et al. · Discover Oncology · 2023 · 15 citations · Full text

Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring <i>MET</i> exon 14 skipping alterations: a <i>post hoc</i> analysis of a pivotal phase 2 study

Yongfeng Yu, Yongxin Ren, Jian Fang et al. · Therapeutic Advances in Medical Oncology · 2022 · 14 citations · Full text

Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial.

Li Zhang, Wen‐Feng Fang, Yuanyuan Zhao et al. · Journal of Clinical Oncology · 2024 · 11 citations